Correlation Between Prime Medicine, and Adaptive Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Prime Medicine, and Adaptive Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prime Medicine, and Adaptive Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prime Medicine, Common and Adaptive Biotechnologies Corp, you can compare the effects of market volatilities on Prime Medicine, and Adaptive Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prime Medicine, with a short position of Adaptive Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prime Medicine, and Adaptive Biotechnologies.
Diversification Opportunities for Prime Medicine, and Adaptive Biotechnologies
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Prime and Adaptive is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Prime Medicine, Common and Adaptive Biotechnologies Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptive Biotechnologies and Prime Medicine, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prime Medicine, Common are associated (or correlated) with Adaptive Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptive Biotechnologies has no effect on the direction of Prime Medicine, i.e., Prime Medicine, and Adaptive Biotechnologies go up and down completely randomly.
Pair Corralation between Prime Medicine, and Adaptive Biotechnologies
Given the investment horizon of 90 days Prime Medicine, Common is expected to under-perform the Adaptive Biotechnologies. But the etf apears to be less risky and, when comparing its historical volatility, Prime Medicine, Common is 1.06 times less risky than Adaptive Biotechnologies. The etf trades about -0.05 of its potential returns per unit of risk. The Adaptive Biotechnologies Corp is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 512.00 in Adaptive Biotechnologies Corp on August 30, 2024 and sell it today you would earn a total of 61.00 from holding Adaptive Biotechnologies Corp or generate 11.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Prime Medicine, Common vs. Adaptive Biotechnologies Corp
Performance |
| Timeline |
| Prime Medicine, Common |
| Adaptive Biotechnologies |
Prime Medicine, and Adaptive Biotechnologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Prime Medicine, and Adaptive Biotechnologies
The main advantage of trading using opposite Prime Medicine, and Adaptive Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prime Medicine, position performs unexpectedly, Adaptive Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptive Biotechnologies will offset losses from the drop in Adaptive Biotechnologies' long position.| Prime Medicine, vs. Beam Therapeutics | Prime Medicine, vs. Caribou Biosciences | Prime Medicine, vs. Intellia Therapeutics | Prime Medicine, vs. Sana Biotechnology |
| Adaptive Biotechnologies vs. Verve Therapeutics | Adaptive Biotechnologies vs. Beam Therapeutics | Adaptive Biotechnologies vs. Caribou Biosciences | Adaptive Biotechnologies vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |